For US residents only.

Understanding TABRECTA

TABRECTA^® (capmatinib) tablets

< Back To Site

Prescribing Info, including Patient Info

Patient Support Line 1-800-282-7630
Mon-Fri: 9 am – 5 pm ET

Important Safety Information

TABRECTA may cause serious side effects. Tell your health care provider right away if you get any of the following:

Lung or breathing problems. TABRECTA may cause inflammation of the lungs that can ca...

Approved Use

TABRECTA is a prescription medicine used to treat adults with a kind of lung cancer called non-small cell lung cancer (NSCLC) that:

has spread to other parts of the body (metastatic), and
whose tumors have an abnormality in their mesenchymal-epithelial transition (MET) gene. Your health care provider will perform a test to make sure that TABRECTA is right for you

It is not known if TABRECTA is safe and effective in children.

TABRECTA works by blocking the activity of proteins made by MET exon 14 skipping that can cause your cancer to grow

TABRECTA affects both cancer cells and healthy cells
Although TABRECTA has been studied in people with NSCLC, how TABRECTA works has been demonstrated only in laboratory studies

Learn about treatment results with TABRECTA